Botanical species · safety record

Ajuga reptans

The EFSA Compendium of Botanicals holds 2 constituent measurements for Ajuga reptans. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ajuga reptans L.

2Constituent measurements
0Safety records
2Cited sources
7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Ajuga reptans as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aerial parts
  • Fresh whole flowering plant
  • Leaf
  • Plante entière
  • Whole plant

What the records describe

Constituents measured

  • Clerodane-type diterpenes2

Plant parts

  • Aerial part of plants2

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Clerodane-type diterpenesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Clerodane-type diterpenesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Malakov, PY., Papanov, GY. Areptins A and B two new neo-clerodane diterpenoids from Ajuga reptans. Phytochemistry, 1998, vol. 49, no. 8, p. 2443-2447. DOI
  2. Carbonell, P., Coll, J. Ajugatansins, neo-clerodane diterpenes from Ajuga reptans. Phytochemical analysis, 2001, vol. 12, no. 1, p. 73-78. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue